Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 06, 2021

SELL
$13.25 - $15.13 $133,215 - $152,117
-10,054 Closed
0 $0
Q2 2021

Jul 06, 2021

SELL
$12.97 - $16.15 $17,509 - $21,802
-1,350 Reduced 11.84%
10,054 $144,000
Q1 2021

Apr 08, 2021

SELL
$13.59 - $18.54 $31,488 - $42,957
-2,317 Reduced 16.89%
11,404 $160,000
Q4 2020

Mar 04, 2021

BUY
$14.3 - $18.74 $196,210 - $257,131
13,721 New
13,721 $257,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Neville Rodie & Shaw Inc Portfolio

Follow Neville Rodie & Shaw Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neville Rodie & Shaw Inc, based on Form 13F filings with the SEC.

News

Stay updated on Neville Rodie & Shaw Inc with notifications on news.